Medication

Approved indication: KYGEVVI™ (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase…

Most New Zealanders like to think we could take care of ourselves and survive in the event of…

Srinagar, Nov 7: The High Court of Jammu and Kashmir and Ladakh on Friday closed a Public Interest…

The study, set to be commissioned soon and completed four months after that, will aim to identify bacterial…

Presbyopia comes with age, and yes, it’s annoying. It forces you to stop reading, move your phone farther…

ATLANTA — Several lots of an ADHD medication has been recalled over concerns revealed by testing. Sun Pharmaceutical…

More than 140,000 bottles of a popular prescription medication used to treat high cholesterol have been recalled because…

During the colder months of autumn and winter, some households have taken to burning this herb as a…

President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr. doubled down on their controversial…

CHARLOTTE — Thousands of bottles of cholesterol medicine were recalled this week because the pills may not dissolve…

New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…

During the colder months of autumn and winter, some households have taken to burning this herb as a…

U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)